Ophthalmology

New RNAi treatment targets eye inflammation

Scientists have developed a new RNA interference (RNAi) therapeutic agent that safely blocked ocular inflammation in mice, potentially making it a new treatment for human uveitis and diabetic retinopathy.

Ophthalmology

Researchers develop new model for earlier treatments for AMD

An international team of researchers from Queen's University Belfast, University College London and the University of Alabama at Birmingham, USA have developed a cell culture model that could help to develop earlier treatment ...

Genetics

Induced pluripotent stem cells don't increase genetic mutations

It's been more than 10 years since Japanese researchers Shinya Yamanaka, M.D., Ph.D., and his graduate student Kazutoshi Takahashi, Ph.D., developed the breakthrough technique to return any adult cell to its earliest stage ...

Ophthalmology

Self-care tools cut depression in AMD, diabetic retinopathy

(HealthDay)—Self-care tools can reduce depressive symptoms in patients with age-related macular degeneration (AMD) or diabetic retinopathy (DR), according to a study published online Dec. 7 in Clinical & Experimental Ophthalmology.

page 18 from 39